Singapore: Thermo Fisher Scientific has completed 20th year of its operation in Singapore. The company celebrated the mi...
Singapore: The US FDA has granted priority review classification to Vanda's New Drug Application (NDA) for tasimelteon, ...
Singapore: Phase III studies by Novartis has demonstrated that Jakavi (INC424, ruxolitinib) treatment resulted in sustai...
Singapore: Quest PharmaTech, a pharmaceutical company developing and commercializing products for the treatment of cance...
Singapore: European Commission has approved Novartis' Bexsero (Meningococcal Group B Vaccine [rDNA, component, adsorbed]...
Singapore: Crystal Pharmatech is going to open its laboratories in China in order to provide customized, materials scie...
Singapore: ShangPharma, a China-based pharmaceutical and biotechnology research and development outsourcing company, cel...
Singapore: Breakthrough Prize in Life Sciences Foundation has opened its process of online nomination for the 2014 prize...
Singapore: Australian drug discovery firm, Bionomics, has received positive results in the phase I clinical trial of its...
Singapore: A study by University of Michigan Comprehensive Cancer Center researchers demonstrated that a new drug has dr...
Singapore: Japan-based pharmaceutical company Shionogi has launched its new European Headquarters in London, UK, to be c...
Singapore: US-based Tetraphase Pharmaceuticals has received approval from US FDA for its lead antibiotic product candida...
Singapore: Clinical stage biopharmaceutical company, Ambrx and China's Zhejiang Medicine (ZMC) have formed a collaborati...
Singapore: Novartis plans to ship around 30 million doses of its influenza vaccines including Fluvirin and Flucelvax to ...
Singapore: The US FDA has given a warning to Dr Bernard Doft, a phase III investigator of Genentech's Lucentis macular d...
Singapore: Pall Corporation, a developer of filtration, separation and purification technology, has decided to acquire A...
Singapore: Cervarix has now been approved for use in females aged nine-to-25 years to prevent persistent infection, prem...
Singapore: Australian clinical research organization, Novotech, has partnered with Korea Drug Development Fund (KDDF) to...
